Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7326/ACPJC-2018-168-12-065 | DOI Listing |
Exacerbations of persistent or intermittent asthma should be anticipated by physicians and health-care professionals. Patients who are likely to experience an exacerbation often have a history of an exacerbation in the previous year, and the absolute eosinophil count in peripheral blood is ≥ 400/μL. Similarly, expectorated or induced sputum eosinophilia of ≥2% is associated with exacerbations.
View Article and Find Full Text PDFAnn Allergy Asthma Immunol
October 2019
Rutgers New Jersey Medical School, The State University of New Jersey, Newark, New Jersey. Electronic address:
Objective: To evaluate relevant studies and documents that address treatment strategies for acute loss of asthma control (yellow zone).
Data Sources: Publications available on various treatment strategies for the yellow zone, Global Initiative for Asthma, and FDA Drug Safety Communication.
Study Selections: Studies that assessed the effectiveness of specific therapies as yellow zone strategies were included in this review.
Can Fam Physician
May 2019
Vancouver, BC.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!